Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Lack Reliable Safety Information, Watchdog Warns The wellness world is eager for RFK Jr.'s promised move on peptides : NPR FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA's Overreach on Compounded Peptides